Screening blood biomarkers for osteoarthritis diagnosis
Official title: Screening of Biomarkers for Osteoarthritis and Establishment of a Multidimensional Data Based Early Diagnostic Method
Run by The First Affiliated Hospital of Xinxiang Medical College · NCT07544823 · Data updated 2026-11-12
This project will test whether certain blood biomarkers can help diagnose osteoarthritis in people aged 40–70 who have had joint pain or stiffness for at least three months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years to 70 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | The First Affiliated Hospital of Xinxiang Medical College Academic / other |
| Locations | 1 site (Xinxiang, Henan) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | April 22, 2026 |
| Trial ID | NCT07544823 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–70 with joint pain or stiffness lasting at least three months who can give informed consent and complete imaging, blood draws, and follow-up visits are ideal candidates.
✕Probably not a fit
Patients with other severe joint diseases (such as rheumatoid arthritis or gout), recent joint surgery, severe systemic illness, cognitive impairment, or inability to complete required imaging or follow-up are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect blood samples from patients with diagnosed or suspected osteoarthritis attending the orthopedic outpatient department of a tertiary hospital in Xinxiang. Diagnostic and differential tests, including X-ray and MRI, will be used alongside laboratory analysis to compare previously reported candidate biomarkers with clinical diagnoses. The goal is to identify biomarkers that show reliable validity and reproducibility for early detection or differentiation of OA. Participants must meet inclusion/exclusion criteria and complete required imaging and follow-up visits.
Why it matters
Potential benefit: If successful, validated blood biomarkers could enable earlier and more accurate diagnosis of osteoarthritis, potentially reducing delayed treatment and long-term disability.
How similar studies have gone: Some candidate OA biomarkers have been reported in prior research, but none have been universally validated for routine clinical use, so this project builds on preliminary findings rather than testing an already proven diagnostic.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged between 40 and 70 years (inclusive); 2. Joint pain or stiffness lasting for no less than 3 months; 3. Voluntary participation with signed informed consent. Exclusion Criteria: 1. Combined with other severe joint diseases, such as rheumatoid arthritis, gout, etc.; 2. Suffering from severe systemic diseases, such as heart failure, malignant tumors and others; 3. Received joint surgery within the past 3 months or taking medications that may affect the progression of osteoarthritis; 4. Individuals with cognitive dysfunction who are unable to cooperate with the research procedures; 5. Failure to complete X-ray, MRI examination or follow-up visits as required.
Where it's running
-
The First Affiliated Hospital of Henan Medical University
Xinxiang, Henan, China Recruiting
Study contacts
- Study coordinator: Wenjie Ren
- Email: 157121431@qq.com
- Phone: 8618937302619
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Observational Registry for Dezawa MuseCells Outcomes
This project follows people who were treated with Dezawa MuseCells to see how they’re doing over 5 years using online surveys.
-
Can robotic-assisted knee replacement with functional alignment improve outcomes vs. standard knee replacement?
This trial tests whether using the VELYS robotic system during total knee replacement helps patients with knee osteoarthritis feel better and move more comfortably compared with conventional non-robotic surgery.
-
Post-Operative Pain Relief with Zynrelef vs Periarticular Injections in Robot-Assisted Knee Replacement
This study tests whether the Zynrelef extended-release periarticular injection can reduce pain and opioid use after robot-assisted total knee arthroplasty compared with standard periarticular injections.
-
Impact of pre-operative sarcopenia on recovery after hip replacement in older adults
This study tests whether low muscle mass and strength before hip replacement affect recovery in people 75 and older who have hip fracture or severe osteoarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.